Fingerprint
Dive into the research topics of 'Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically